
Venture capital · Est. 2008
Ysios Capital –
Spanish venture capital firm with offices in Barcelona and San Sebastián that finances biotech companies worldwide developing new therapeutic drugs, managing over 400 million euros across three funds.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Ysios Capital – right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
BetaRounds Ysios Capital – joined, from press and the firm’s own posts.
2 rounds in the last 12 months
Round sizes, Ysios Capital –’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Ysios Capital – backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Ysios Capital –
Events where Ysios Capital –’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Ysios Capital – is based in San Sebastián, Spain. It also has an office in Barcelona. Its registered address is AVENIDA DE LA LIBERTAD, Nº 25, 4º A-B SAN SEBASTIAN GUIPUZCOA 20004.
In 2008.
8 fund vehicles are on public registers (ESMA register), including INCEPTIONBIO INNVIERTE, F.C.R.E., INCEPTIONBIO INNVIERTE, F.C.R.E. and YSIOS BIOFUND I, FCR (EN LIQUIDACIÓN).
Sectors: Biotech, Life sciences. From the firm’s own website.
Backs biotech ventures developing new drugs for serious unmet medical needs, prizing strong management and sound science. Open to any modality and to either single assets or platforms, it concentrates on programs in late preclinical or early clinical development, syndicates with other life science investors, and acts as a hands-on, supportive shareholder with deep pharma-industry ties. From the firm’s own website.
Ysios Capital – lists 38 portfolio companies on its website, including Adcendo, AELIX Therapeutics, AM Pharma, Anaconda Biomed and Aura Biosciences.
Firms whose websites list some of the same companies include Asabys Partners, BioGeneration Ventures and Columbus Venture Partners.
Know before Ysios Capital –’s next round is announced.
PRO tracks Ysios Capital –’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.